A23S (p.Ala23Ser) variant of INS (Insulin)

A23S (p.Ala23Ser) in INS (Insulin) is a missense change. Clinical records from EBI and UniProt describe it as benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.38 / 1. The record also includes population frequency data and structural context.

A23S (p.Ala23Ser) variant details